128 related articles for article (PubMed ID: 36697107)
21. FCGR2A, FCGR3A polymorphisms and therapeutic efficacy of anti-EGFR monoclonal antibody in metastatic colorectal cancer.
Ying HQ; Wang F; Chen XL; He BS; Pan YQ; Jie C; Liu X; Cao WJ; Peng HX; Lin K; Wang SK
Oncotarget; 2015 Sep; 6(29):28071-83. PubMed ID: 26363448
[TBL] [Abstract][Full Text] [Related]
22. Characterization and expression of the human alpha beta T cell receptor by using a framework monoclonal antibody.
Brenner MB; McLean J; Scheft H; Warnke RA; Jones N; Strominger JL
J Immunol; 1987 Mar; 138(5):1502-9. PubMed ID: 3492555
[TBL] [Abstract][Full Text] [Related]
23. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
[TBL] [Abstract][Full Text] [Related]
24. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
[TBL] [Abstract][Full Text] [Related]
25. Antiepidermal growth factor receptor monoclonal antibody improves survival outcomes in the treatment of patients with metastatic colorectal cancer.
Wang L; Chen X; Li W; Sheng Z
Anticancer Drugs; 2012 Feb; 23(2):155-60. PubMed ID: 21955998
[TBL] [Abstract][Full Text] [Related]
26. Triple-drug chemotherapy regimens in combination with an anti-EGFR agent in metastatic colorectal cancer - prospects from phase II clinical trials.
Matos I; Noguerido A; Ros J; Mulet N; Argilés G; Elez É; Tabernero J
Expert Opin Investig Drugs; 2019 May; 28(5):463-471. PubMed ID: 30905200
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection.
Eto M; Yoshikai Y; Nishimura Y; Hiromatsu K; Maeda T; Nomoto K; Kong YY; Kubo RT; Kumazawa J; Nomoto K
Immunology; 1994 Feb; 81(2):198-204. PubMed ID: 8157269
[TBL] [Abstract][Full Text] [Related]
28. Exacerbation of established collagen-induced arthritis in mice treated with an anti-T cell receptor antibody.
Maeda T; Saikawa I; Hotokebuchi T; Sugioka Y; Eto M; Murakami Y; Nomoto K
Arthritis Rheum; 1994 Mar; 37(3):406-13. PubMed ID: 8129796
[TBL] [Abstract][Full Text] [Related]
29. Integration of novel agents in the treatment of colorectal cancer.
Iqbal S; Lenz HJ
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512
[TBL] [Abstract][Full Text] [Related]
30. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
[TBL] [Abstract][Full Text] [Related]
31. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
[TBL] [Abstract][Full Text] [Related]
32. Differential activation through the TCR-CD3 complex affects the requirement for costimulation of human T cells.
Kawaguchi M; Eckels DD
Hum Immunol; 1995 Jun; 43(2):136-48. PubMed ID: 7591873
[TBL] [Abstract][Full Text] [Related]
33. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
[TBL] [Abstract][Full Text] [Related]
34. Two distinct immunogenic epitopes on the alpha chain of human T cell antigen receptor.
Henry L; Tian WT; Rittershaus C; Ko JL; Marsh HC; Ip SH
Hybridoma; 1989 Dec; 8(6):577-88. PubMed ID: 2482248
[TBL] [Abstract][Full Text] [Related]
35. Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies.
Zhang W; Gordon M; Lenz HJ
Ann Med; 2006; 38(8):545-51. PubMed ID: 17438669
[TBL] [Abstract][Full Text] [Related]
36. Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Genet Med; 2013 Jul; 15(7):517-27. PubMed ID: 23429431
[TBL] [Abstract][Full Text] [Related]
37. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
38. Generation and functional characterization of anti-clonotype antibodies to human T-cell receptors.
Steenbakkers PG; Boots AM; Rijnders AW
J Immunol Methods; 1997 Dec; 210(1):51-64. PubMed ID: 9502584
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours.
Rowland A; Dias MM; Wiese MD; Kichenadasse G; McKinnon RA; Karapetis CS; Sorich MJ
Eur J Cancer; 2016 Mar; 55():122-30. PubMed ID: 26812186
[TBL] [Abstract][Full Text] [Related]
40. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.
Matsuda M; Petersson M; Lenkei R; Taupin JL; Magnusson I; Mellstedt H; Anderson P; Kiessling R
Int J Cancer; 1995 Jun; 61(6):765-72. PubMed ID: 7790109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
